All Pharma News
ChromaDex To Launch IV And Injectable Niagen At Wellness Clinics

ChromaDex To Launch IV And Injectable Niagen At Wellness Clinics
BUSINESSWIRE
16 Jul 2024
Share Share
ChromaDex to Join Russell 2000® Index

ChromaDex to Join Russell 2000® Index
BUSINESSWIRE
01 Jul 2024
Share Share
ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharma-Grade IV & Inj Niagen

ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharma-Grade IV & Inj Niagen
BUSINESSWIRE
13 Jun 2024
Share Share
ChromaDex Gets US Orphan, Rare Pediatric Status For NRC In AT

ChromaDex Gets US Orphan, Rare Pediatric Status For NRC In AT
BUSINESSWIRE
07 Jun 2024
Share Share
ChromaDex wins orphan designation for rare ataxia drug

ChromaDex wins orphan designation for rare ataxia drug
Justine Ra PHARMACEUTICAL TECHNOLOGY
07 Jun 2024
Share Share
Chromadex Lytham May 30 Event: Spring 2024 Investor Conference

Chromadex Lytham May 30 Event: Spring 2024 Investor Conference
BUSINESSWIRE
23 May 2024
Share Share
ChromaDex Reports Q1 2024 Results on May 8

ChromaDex Reports Q1 2024 Results on May 8
BUSINESSWIRE
24 Apr 2024
Share Share
ChromaDex Launches Tru Niagen® at Sprouts

ChromaDex Launches Tru Niagen® at Sprouts
BUSINESSWIRE
23 Apr 2024
Share Share
ChromaDex Announces Tru Niagen® is Now Third-Party Verified

ChromaDex Announces Tru Niagen® is Now Third-Party Verified
BUSINESSWIRE
26 Mar 2024
Share Share
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
BUSINESSWIRE
06 Mar 2024
Share Share